United Kingdom: Enhance your understanding of HIV's cognitive impact and assessment with this professional development course. Covers HAND and treatment.
This specialised course from clinical neuropsychologist Digby Ormond-Brown examines how HIV affects brain function and cognition. UK psychologists will review the virus's pathophysiology and its effect on neurological structures, then learn the diagnostic criteria for HIV-Associated Neurocognitive Disorder, which ranges from asymptomatic impairment to dementia. The course explains how HAND is measured through neuropsychological assessment and looks at biomarkers and antiretroviral treatment. It suits clinicians in health, neuropsychology or community roles who want more confidence identifying cognitive change linked to HIV.
This specialised talk , presented by experienced Clinical Neuropsychologist Digby Ormond-Brown, explores the neuropsychological impact of HIV, with a particular focus on HIV’s effects on brain function and cognition. The session begins with a concise overview of HIV pathophysiology, highlighting how the virus affects neurological structures.
Participants will gain a clear understanding of HIV-Associated Neurocognitive Disorder (HAND), including the spectrum of severity from asymptomatic neurocognitive impairment to HIV-associated dementia. Digby also outlines how HAND is identified and measured through neuropsychological assessment tools, and examines the role of biomarkers and the potential neuroprotective effects of antiretroviral treatment.
This talk is ideal for psychologists working in health, neuropsychology, or community settings who want to increase their confidence in identifying and understanding the cognitive implications of HIV.
Sections
Learning Outcomes
By the end of this talk, participants will be able to:
Describe how HIV affects the brain and cognition.
Understand the diagnostic criteria for HIV-Associated Neurocognitive Disorder (HAND).
Identify appropriate neuropsychological assessment methods for HAND.
Interpret the relevance of biomarkers in cognitive impairment related to HIV.
Consider the cognitive and neurological impact of antiretroviral therapy.